Streetbeat News

Regulatory

SSKN

STRATA Skin Sciences (SSKN) has been granted a 180-day extension, until June 24, 2024, by Nasdaq to meet the minimum bid price requirement for continued listing.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 1:16 pm

RSI

Delaware Lottery has launched its first online sportsbooks and relaunched its three online casinos, all powered by Rush Street Interactive (RSI). Delaware residents aged 21 and over can now place bets on various devices including mobile phones, tablets, desktops, and laptops.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 1:09 pm

INO

Inovio Pharmaceuticals plans to submit a marketing application to the FDA for INO-3107, aimed at treating Recurrent Respiratory Papillomatosis, in the second half of 2024. The company anticipates being prepared to launch the treatment in 2025.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 1:03 pm

BKNG

RYAAY

Ryanair Holdings PLC (NASDAQ: RYAAY) stock is trading lower after the company reported its December data, which included a 9% increase in guest count but a 1 percentage point decrease in load factor year-over-year. The company also announced that its flights were removed from several OTA websites, including Booking Holdings Inc. (NASDAQ: BKNG) platforms, due to regulatory pressures. This removal is expected to reduce short-term load factors by 1-2% in December and January and weaken yields. Ryanair plans to lower fares to mitigate the impact and does not anticipate a material effect on its FY24 traffic or profit after tax (PAT) guidance. RYAAY shares dropped 3.16% in premarket trading.

Portfolio Pulse from Lekha Gupta

January 03, 2024 | 12:39 pm

AAPL

Apple Inc. (NASDAQ:AAPL) has been granted a patent for a new feature for the Vision Pro's external display, which could show what the wearer is seeing or other animations. This innovation comes amid rumors of a display overhaul for the Vision Pro 2 and the anticipated launch of the $3,500 Vision Pro headset in the last week of January, earlier than expected.

Portfolio Pulse from Rounak Jain

January 03, 2024 | 12:32 pm

VIRI

Virios Therapeutics, in a letter to shareholders, announced that they are exploring options to advance their IMC-1 LC Investigational New Drug Application and its proposed Phase 2 research program.

Portfolio Pulse from Charles Gross

January 03, 2024 | 12:11 pm

LEAS

SEALSQ announced the launch of SEALCOIN, a new digital token and advanced cryptocurrency protocol, at the Davos Space IoT and Cybersecurity event on January 17. This development could signal SEALSQ's entry into the blockchain and cryptocurrency market, potentially expanding its business model and offerings.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 12:09 pm

APLT

Applied Therapeutics announced the validation of its Marketing Authorization Application (MAA) and the submission of a New Drug Application (NDA) for Govorestat (AT-007) for the treatment of Classic Galactosemia. The submissions are based on positive results from the Phase 3 ACTION-Galactosemia Kids study.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 12:08 pm

IVVD

Invivyd, Inc. (NASDAQ:IVVD) has submitted a request for Emergency Use Authorization (EUA) to the U.S. FDA for its monoclonal antibody candidate VYD222, aimed at preventing COVID-19 in immunocompromised individuals. The submission is supported by positive results from the CANOPY Phase 3 trial and ongoing in vitro activity against variants like JN.1.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 12:05 pm

NA

Nano Labs Ltd (NASDAQ:NA), a Chinese fabless integrated circuit design company, has announced that Citibank N.A., the depositary for the company's ADRs, has issued a notification about the amendment to the deposit agreement and the termination of the ADR facility. The termination will be effective on February 1, 2024. This could affect the holders and beneficial owners of Nano Labs' ADRs.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 12:04 pm